Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cécile Ortholan

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
La Revue Du Praticien|January 5, 2011
[Rectal cancer: which initial strategy?]Jean-Pierre Gérard, Cécile Ortholan
Bulletin Du Cancer|January 7, 2006
[Chemoradiotherapy and anal canal cancer]Cécile Ortholan, Eric François, Jean-Pierre Gérard
Bulletin Du Cancer|July 10, 2003
[Preneoplastic anal lesions and anal canal carcinoma]Cécile Ortholan, Eric François, Jean-Pierre Gérard
International Journal of Radiation Oncology, Biology, Physics|May 15, 2012
Correlation in rectal cancer between clinical tumor response after neoadjuvant radiotherapy and sphincter or organ preservation: 10-year results of the Lyon R 96-02 randomized trialCécile Ortholan, Pascale Romestaing, Olivier Chapet, et al.
Bulletin Du Cancer|February 18, 2006
[Oxaliplatin and preoperative chemoradiotherapy in rectal cancer]Cécile Ortholan, Eric Francois, Philippe Follana, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 30, 2025
Hypofractionated radiotherapy for head and neck squamous cell carcinomaDylan Bocha, Jennifer Le Guevelou, Cécile Ortholan, et al.
Brachytherapy|December 3, 2014
Total radiation dose and overall treatment time are predictive for tumor sterilization in cervical carcinoma treated with chemoradiation and pulsed-dose-rate brachytherapyLorraine Krebs, Sophie Maillard, Nathalie Gaillot-Petit, et al.
Current Medicinal Chemistry|March 12, 2009
MicroRNAs and lung cancer: new oncogenes and tumor suppressors, new prognostic factors and potential therapeutic targetsCécile Ortholan, Marie-Pierre Puissegur, Marius Ilie, et al.
Bulletin Du Cancer|August 12, 2017
[A French multicenter research program for a personalized treatment of elderly head and neck cancer patient]Joël Guigay, Cécile Mertens, Hervé Le Caer, et al.
International Journal of Radiation Oncology, Biology, Physics|January 5, 2005
Long-term results of adjuvant hypofractionated radiotherapy for breast cancer in elderly patientsCécile Ortholan, Jean-Michel Hannoun-Lévi, Jean-Marc Ferrero, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
La Revue Du Praticien|January 5, 2011
[Rectal cancer: which initial strategy?]Jean-Pierre Gérard, Cécile Ortholan
Bulletin Du Cancer|January 7, 2006
[Chemoradiotherapy and anal canal cancer]Cécile Ortholan, Eric François, Jean-Pierre Gérard
Bulletin Du Cancer|July 10, 2003
[Preneoplastic anal lesions and anal canal carcinoma]Cécile Ortholan, Eric François, Jean-Pierre Gérard
International Journal of Radiation Oncology, Biology, Physics|May 15, 2012
Correlation in rectal cancer between clinical tumor response after neoadjuvant radiotherapy and sphincter or organ preservation: 10-year results of the Lyon R 96-02 randomized trialCécile Ortholan, Pascale Romestaing, Olivier Chapet, et al.
Bulletin Du Cancer|February 18, 2006
[Oxaliplatin and preoperative chemoradiotherapy in rectal cancer]Cécile Ortholan, Eric Francois, Philippe Follana, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 30, 2025
Hypofractionated radiotherapy for head and neck squamous cell carcinomaDylan Bocha, Jennifer Le Guevelou, Cécile Ortholan, et al.
Brachytherapy|December 3, 2014
Total radiation dose and overall treatment time are predictive for tumor sterilization in cervical carcinoma treated with chemoradiation and pulsed-dose-rate brachytherapyLorraine Krebs, Sophie Maillard, Nathalie Gaillot-Petit, et al.
Current Medicinal Chemistry|March 12, 2009
MicroRNAs and lung cancer: new oncogenes and tumor suppressors, new prognostic factors and potential therapeutic targetsCécile Ortholan, Marie-Pierre Puissegur, Marius Ilie, et al.
Bulletin Du Cancer|August 12, 2017
[A French multicenter research program for a personalized treatment of elderly head and neck cancer patient]Joël Guigay, Cécile Mertens, Hervé Le Caer, et al.
International Journal of Radiation Oncology, Biology, Physics|January 5, 2005
Long-term results of adjuvant hypofractionated radiotherapy for breast cancer in elderly patientsCécile Ortholan, Jean-Michel Hannoun-Lévi, Jean-Marc Ferrero, et al.
Pageof 4